Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Systematic Review of the Protective Effect of Prior SARS-CoV-2 Infection on Repeat Infection
Noah Kojima, Nabin K. Shrestha, Jeffrey D. Klausner
Evaluation & the Health Professions (2021) Vol. 44, Iss. 4, pp. 327-332
Open Access | Times Cited: 90

Showing 26-50 of 90 citing articles:

Viral kinetics of sequential SARS-CoV-2 infections
Stephen M. Kissler, James A. Hay, Joseph R. Fauver, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Prognostic value of anti-SARS-CoV-2 antibodies: a systematic review
Sylvia Mink, Patrick Reimann, Peter Fraunberger
Clinical Chemistry and Laboratory Medicine (CCLM) (2024) Vol. 62, Iss. 6, pp. 1029-1043
Open Access | Times Cited: 6
Estimating protection afforded by prior infection in preventing reinfection: Applying the test-negative study design
Houssein H. Ayoub, Milan Tomy, Hiam Chemaitelly, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 27
Duration of immune protection of SARS-CoV-2 natural infection against reinfection in Qatar
Hiam Chemaitelly, Nico Nagelkerke, Houssein H. Ayoub, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 24
Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational study
Suelen H. Qassim, Hiam Chemaitelly, Houssein H. Ayoub, et al.
EClinicalMedicine (2023) Vol. 62, pp. 102102-102102
Open Access | Times Cited: 13
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19—VISION Network, 10 States, June 2021–March 2023
Eric P. Griggs, Patrick K. Mitchell, Victoria Lazariu, et al.
Clinical Infectious Diseases (2023) Vol. 78, Iss. 2, pp. 338-348
Open Access | Times Cited: 13
Decoding the paradox: Understanding Elevated Hospitalization and Reduced Mortality in SARS-CoV-2 Variants
Sunil J. Wimalawansa
International Journal of Frontiers in Science and Technology Research (2024) Vol. 6, Iss. 2, pp. 001-020
Open Access | Times Cited: 4
Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage
Hiam Chemaitelly, Houssein H. Ayoub, Peter Coyle, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 21
Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trial
Igor Smolenov, Htay Htay Han, Ping Li, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 7, pp. 990-1001
Open Access | Times Cited: 20
Effectiveness of the neutralizing antibody sotrovimab among high-risk patients with mild-to-moderate SARS-CoV-2 in Qatar
Ahmed Zaqout, Muna Almaslamani, Hiam Chemaitelly, et al.
International Journal of Infectious Diseases (2022) Vol. 124, pp. 96-103
Open Access | Times Cited: 20
Addressing bias in the definition of SARS-CoV-2 reinfection: implications for underestimation
Hiam Chemaitelly, Houssein H. Ayoub, Patrick Tang, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 3
SARS-CoV-2 Transmission and Prevention in the Era of the Delta Variant
Eric A. Meyerowitz, Aaron Richterman
Infectious Disease Clinics of North America (2022) Vol. 36, Iss. 2, pp. 267-293
Open Access | Times Cited: 17
Risk of and duration of protection from SARS-CoV-2 reinfection assessed with real-world data
Shannon L. Reynolds, Harvey W. Kaufman, William A. Meyer, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0280584-e0280584
Open Access | Times Cited: 9
Hybrid Immunity Provides Protective Advantage Over Vaccination or Prior Remote Coronavirus Disease 2019 Alone
Abinash Virk, Matthew G. Johnson, Daniel Roellinger, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 5
Open Access | Times Cited: 9
History of primary-series and booster vaccination and protection against Omicron reinfection
Hiam Chemaitelly, Houssein H. Ayoub, Patrick Tang, et al.
Science Advances (2023) Vol. 9, Iss. 40
Open Access | Times Cited: 9
An immune correlate of SARS-CoV-2 infection and severity of reinfections
Hannah E. Maier, Ángel Balmaseda, Sergio Ojeda, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 22
SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection
Jia Wei, Philippa C. Matthews, Nicole Stoesser, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 14
COVID-19 primary series and booster vaccination and potential for immune imprinting
Hiam Chemaitelly, Houssein H. Ayoub, Patrick Tang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 14
SARS-CoV-2 - The Role of Natural Immunity: A Narrative Review
Sara Diani, Erika Leonardi, Attilio Cavezzi, et al.
(2022)
Open Access | Times Cited: 13
Effects of BA.1/BA.2 subvariant, vaccination, and prior infection on infectiousness of SARS-CoV-2 Omicron infections
Suelen H. Qassim, Hiam Chemaitelly, Houssein H. Ayoub, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 12
Protection of prior natural infection compared to mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar
Hiam Chemaitelly, Houssein H. Ayoub, Sawsan AlMukdad, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 12
Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infections
Suelen H. Qassim, Mohammad R. Hasan, Patrick Tang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Short- and longer-term all-cause mortality among SARS-CoV-2-infected persons and the pull-forward phenomenon in Qatar
Hiam Chemaitelly, Jeremy Samuel Faust, Harlan M. Krumholz, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
Maintaining immunological memory to the SARS-CoV-2 virus during COVID-19 pandemic
А. П. Топтыгина, Z. E. Afridonova, Р. Ш. Закиров, et al.
Russian Journal of Infection and Immunity (2023) Vol. 13, Iss. 1, pp. 55-66
Open Access | Times Cited: 7
Impact on the time elapsed since SARS-CoV-2 infection, vaccination history, and number of doses, on protection against reinfection
Laura Sánchez-de Prada, Ana María Martínez-García, Belén González-Fernández, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2

Scroll to top